Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
CTR20262896 ZOC2019619 Glaucoma, Open-Angle Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262896 ZOC2019619 Glaucoma, Open-Angle Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
CTR20262896 clinical trial report covering ZOC2019619, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262894 ZOC2019619 Glaucoma, Open-Angle Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262894 ZOC2019619 Glaucoma, Open-Angle Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
CTR20262894 clinical trial report covering ZOC2019619, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07738198 Stannous protoporphyrin Hypersensitivity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07738198 Stannous protoporphyrin Hypersensitivity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07738198 clinical trial report covering Stannous protoporphyrin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07739654 Cisplatin Diffuse large B-cell lymphoma recurrent Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07739654 Cisplatin Diffuse large B-cell lymphoma recurrent Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07739654 clinical trial report covering Cisplatin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07739914 Everolimus Liver Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07739914 Everolimus Liver Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07739914 clinical trial report covering Everolimus, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07738172 Osimertinib mesylate EGFR-mutated non-small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07738172 Osimertinib mesylate EGFR-mutated non-small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07738172 clinical trial report covering Osimertinib mesylate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07740421 NH-002(Trust Bio-sonics) Heart Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07740421 NH-002(Trust Bio-sonics) Heart Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07740421 clinical trial report covering NH-002(Trust Bio-sonics), Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07738276 Tirzepatide Heart failure with normal ejection fraction Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07738276 Tirzepatide Heart failure with normal ejection fraction Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07738276 clinical trial report covering Tirzepatide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07740564 OT-202 Dry Eye Syndromes Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07740564 OT-202 Dry Eye Syndromes Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07740564 clinical trial report covering OT-202, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07739758 Serplulimab Extensive stage Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07739758 Serplulimab Extensive stage Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07739758 clinical trial report covering Serplulimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07741240 KH-607 Depressive Disorder, Major Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07741240 KH-607 Depressive Disorder, Major Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07741240 clinical trial report covering KH-607, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07743164 Raludotatug deruxtecan Ovarian Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07743164 Raludotatug deruxtecan Ovarian Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07743164 clinical trial report covering Raludotatug deruxtecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →